Much of the evidence currently available on survival benefit of repeat resection for rGB has been obtained through literature-based comparison [1, 16] or includes heterogenous patient groups, including together varying IDH subtypes and anaplastic astrocytomas [1, 29]. This evidence concerns the gene IDH1 and anaplastic astrocytoma.